Baron Growth Instl (BGRIX)
Nasdaq - Nasdaq Delayed Price. Currency in USD
- Business Wire•10 months agoOver 5,000 Baron Funds' Shareholders Listen to Elon Musk and Alicia Keys at 24th Annual Baron Investment Conference
The 24th Annual Baron Investment Conference drew over 5,000 Baron Funds' shareholders today at the Metropolitan Opera House at Lincoln Center in New York City.
- Reuters•10 months ago
The $7 billion Baron Growth fund initiated positions in biotechnology firms Atara Biotherapeutics Inc and ConforMIS Inc during a sell-off in biotech companies last quarter, according to a letter to shareholders. Atara looks attractive because of its T-cell therapy that targets cancer-specific antigens, fund manager Ron Baron wrote. ConforMIS, meanwhile, uses 3D printing technology to develop custom implants for joint replacement procedures and is well-positioned to take market share, he wrote.
We're sorry this is all we were able to find about this topic.